[{"data": {"name": "Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "P M Fracasso", "@type": "Person"}, {"name": "K A Blum", "@type": "Person"}, {"name": "M K Ma", "@type": "Person"}, {"name": "B R Tan", "@type": "Person"}, {"name": "L P Wright", "@type": "Person"}, {"name": "S A Goodner", "@type": "Person"}, {"name": "C L Fears", "@type": "Person"}, {"name": "W Hou", "@type": "Person"}, {"name": "M A Arquette", "@type": "Person"}, {"name": "J Picus", "@type": "Person"}, {"name": "A Denes", "@type": "Person"}, {"name": "J E Mortimer", "@type": "Person"}, {"name": "L Ratner", "@type": "Person"}, {"name": "S P Ivy", "@type": "Person"}, {"name": "H L McLeod", "@type": "Person"}], "license": "cc-by-nc-sa", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.nature.com/articles/6602653.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Springer Nature", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1038/sj.bjc.6602653", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCbm1dMUi8rYY-CTL73MM6vFRGe-CDrYwRmwBkvo5-CRLnVgUGQkmTH", "propertyID": "ISCC"}], "datePublished": "2005-06-07"}, "schema": "schema.org", "mediatype": "application/ld+json"}]